ACT stock

Is Enact Holdings Inc (ACT) overvalued? · P/E 9.3, rev $1.20B

Enact Holdings Inc (ACT) is a insurance - specialty company listed on NASDAQ.

This page asks whether Enact Holdings Inc (ACT) looks expensive on cached numbers — not a short thesis.

Latest reported ACT revenue for 2024-12-31 was $1.20B. Revenue was up 4.2% from 2023-12-31 to 2024-12-31. ACT currently screens at market cap $5.99B and trailing P/E 9.3.

ACT currently screens at market cap $5.99B and trailing P/E 9.3. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.

If the next ACT 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.

Not investment advice. Use the ACT stock page for the full model, not this heading.

Not investment advice.

Full ACT analysis